학술논문
Efficacy and safety of abemaciclib alone and with PI3K/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trial
Document Type
Article
Author
Source
In: Cancer Medicine . (Cancer Medicine, October 2023, 12(20):20353-20364)
Subject
Language
English
ISSN
20457634